Theator’s Intelligence Platform – A New Aspect of AI’s Future in Surgery

Theator Inc. is a startup company with a surgical intelligence platform that leverages AI and computer vision to analyze key moments of surgical procedures. The platform intelligently curates moments from surgeries for surgeons to review…

Revolutionary Advancements in Portable Ultrasound – The Patent Data Told us First

In recent years ultrasound has become increasingly portable, easy to use, and cost-efficient. It is also safer than other medical imaging modalities because it does not expose patients to ionizing radiation, and it can be used to diagnose…

The Race to Non-Invasive Glucose Monitoring – A New Competitor

In July 2021, Patent Forecast provided an overview of glucose monitoring and the major players racing to successfully monitor glucose with non-invasive methods. This week a new player entered this race with a patent application assigned to…

AI Meets Virtual Healthcare

Outpatient care is increasingly provided via telehealth consultations. According to a study published in the Journal of the American Informatics Association, virtual urgent care visits grew by 600% and nonurgent virtual visits grew by…

AI is the Future of Orthopaedic Surgery

Orthopaedic surgeries require substantial force to properly insert an implant for a patient. Some orthopaedic surgeries require a surgeon to hammer an implant to align in with a patient's autonomy. One problem with this is that surgeons…

We Called It – Fitbit partners with LifeScan

The announcement of Fitbit’s partnership with LifeScan comes not even two weeks after Patent Forecast® predicted that smartwatch device leaders such as Fitbit, Apple, and Samsung would need to be part of future partnerships to compete with…

Time For Your TV To Track Your Calories

It’s said that abs are made in the kitchen, but now it might be possible from your couch. This is great news for Americans, who on average spend over 4 hours a day watching TV!  Sony was issued a patent for monitoring the health condition…

Dexcom and the Race to Non-Invasive Glucose Monitoring

Dexcom leads glucose monitoring in the AI Biotech Patent Forecast® with 48 patent assets as shown in the radian above. So far, the company’s main focus has been making its continuous glucose monitoring (CGM) systems compatible with major…

Flow Acquires Halo Neuro and its 28 Patent Assets – Now What?

Neuromodulation is technology that alters nerve activity by delivering electrical or chemical signals directly to a target area. Flow Neuroscience uses such technology to treat depression, which is associated with lower neural activity in…

BostonGene is Growing Quickly – How will Veracyte React?

BostonGene is a quickly growing biomedical software startup that uses its intelligent interactive platform to assist physicians in finding the most effective strategy for precision cancer therapy. This is done using the BostonGene Tumor…

Bardy Diagnostics, Preventice, and Biotelemetry Acquired – Who’s next?

In June 2020 Patent Forecast highlighted an up and coming company, Bardy Diagnostics. At the time, the company had 7 patent assets in the AI Biotech Patent Forecast® regarding its CAM patch, a wearable ECG monitor with improved long-term…

Veracyte Fills Holes in Patent Portfolio – Now Able to Detect 8 of the 10 Most Common Cancers

Veracyte has 24 patent assets in the AI Biotech Patent Forecast® radian relating to molecular profiling and algorithms used for diagnosing diseases and identifying biomarkers. The company’s most recent publication, filed in 2020,…

Google Restructures Its Health Division – Patent Data Will Predict The Next Steps

As Google restructures its health unit, patent activity will be key to predicting its future endeavors. This was previously shown when Patent Forecast® predicted Google’s acquisition of Fitbit in 2019. This $2.1B acquisition was closed as…

How Cognoa’s Use Of AI Is Transforming Diagnostic Procedure For Children

Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions. The company announced June 2nd, 2021 that the FDA granted its De Novo classification…

Microsoft Takes A Nuanced Approach to AI Healthcare

Artificial intelligence has become an invaluable tool in neuroscience due to its ability to vastly improve our understanding of the human brain, and therefore make us better equipped to diagnose and treat neurological disorders. Emerging…

RetinAI, Novartis, and Sankara remain vulnerable to competitors

AI has become the state-of-the-art method for vision tasks such as image classification and deep learning algorithms have been used successfully in ophthalmology to detect diseases such as diabetic retinopathy, age-related macular…

There’s A Patent Gap In AI Dermatology And Google May Be In Trouble

In May 2021, Google announced an artificial intelligence dermatology tool designed to help users understand issues with their skin, hair, and nails from the comfort of their own homes. The tool requires a user to take a picture of their…

AI is the Future for Surgery. Stryker Knows It.

It has been five years since Wright and Tornier merged and adopted the Wright Medical Group name. Stryker then acquired Wright Medical Group in 2020. The acquisition is an IP boon to Stryker, as Wright Medical had 16 patent assets publish…

Is T-Mobile Developing a Wearable?

Have you ever looked at your phone and immediately felt your stress and blood pressure increase due to a phone call? What if you had a wearable device that is able to correlate your stress with a phone call and screen the call for…

Closedloop.Ai Has Stiff Competitors, No Patents. Cue Ominous Shark Soundtrack.

It is important to protect your inventions but apparently AI biotech software companies such as  Closedloop.AI and others don’t see it that way. This may be the result of disarray caused by Alice in 2014 or the constant change in guidance…

Why Patent Assets Helped Secure $80 Million for Tesseract Health

Patent assets provide competitive advantage for a company, even when it is not the first entrant to a market. Retinal imaging and artificial intelligence is not a new concept (See (1) RetinAi,  (2) Diagnos, (3) PixelPlex, and (4) DeepMind…

Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest for promotion, it might have exaggerated a bit.  In early April 2021, Cala Health had 2 patent…

Capital One is Investing in AI Biotech? What’s in their wallet?

In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they belong? While 2 assets in 18 months may not seem substantial on the surface, the AI Biotech field is…

Google AI Reinvents Speech Recognition. Who will follow?

There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in many areas - except perhaps one. For example, of the big 5, only Google has patent data in the…

Sony is Exploring the AI/Biotech Diagnostics Sector. Ask us how we know.

When people think of Sony products, they usually think of audio, visual, and storage devices. That is because a majority of Sony's products fall into one of these categories. However, Sony's recent patent activity suggests that it may be…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS